SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Carson O. Ray, Jr. who wrote (187)2/16/2000 10:50:00 PM
From: Carson O. Ray, Jr.  Read Replies (1) of 258
 
Term Formula Released in Two More Countries...
(BW HealthWire)--Feb. 9, 2000--Martek Biosciences Corporation (NASDAQ: MATK - news) today announced that its nutritional oils have been introduced in a premium term infant formula in the Philippines and Saudi Arabia. Martek's oils have been already introduced in over 60 countries primarily in pre-term infant formula. During the past 24 months, Martek's licensees have introduced premium term infant formula in 7 additional countries.

``Better formula is good business,' said Henry Linsert, Jr., Martek's Chairman and CEO. ``Parents around the world have voted with their wallets to buy the best nutrition for their children. I believe that these two new product introductions will be the first of many to reach the marketplace this year.'

You tell 'em, Henry. Abbott can't keep the FDA stalling forever. Our day will come.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext